Roundtable Discussion: What is the Future of the Obesity Landscape: What Will the Next Generation of Obesity Therapeutics Look Like?
Time: 1:00 pm
day: Conference Day Two
Details:
As we stand on the brink of a new era in obesity treatment, the question remains: What will define the next generation of obesity therapeutics? With the rapid advancements in GLP-1 agonists, the emergence of novel targets, and the growing interest in combination and sequential therapies, the landscape is evolving at an unprecedented pace.
This interactive session gives you the opportunity to be part of the discussion, get ready to share ideas and learn from your peers. Amongst your tables talking points to consider include:
- How can we optimize GLP-1 receptor agonists to enhance efficacy, safety, and patient adherence?
- What novel targets hold the most promise for the next wave of obesity therapeutics?
- Do we see combinatory approaches revolutionizing obesity treatment? What synergies should we be exploring to maximize therapeutic outcomes?
- How can sequential therapies be structured to offer sustained weight loss and long-term metabolic benefits?
Join your peers in this roundtable discussion to brainstorm, share insights, and collectively envision the next breakthroughs!